Behavior of Lipiodol Markers During Image Guided Radiotherapy of Bladder Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 1, 2010, Pages 309-314

  Chai, Xiangfei ^a   van Herk, Marcel ^b   van de Kamer, Jeroen B ^a   Remeijer, Peter ^b   Bex, Axel ^b   Betgen, Anja ^b   De Reijke, Theo M ^a   Hulshof, Maarten C C M ^a   Pos, Floris J ^b   Bel, Arjan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Bladder cancer; IGRT; Lipiodol; Tumor deformation

Indexed keywords

ANTERIOR-POSTERIOR DIRECTIONS; BLADDER CANCERS; BLADDER TISSUE; BLADDER TUMOR; BLADDER WALL; CONEBEAM CT; IGRT; IMAGE GUIDANCES; IMAGE GUIDED RADIOTHERAPY; LIPIODOL; PLANNING CT; RELATIVE MOVEMENT; SPOT SIZES;

COMPUTERIZED TOMOGRAPHY; DEFORMATION;

TUMORS;

BIOLOGICAL MARKER; IODINATED POPPYSEED OIL;

ADULT; AGED; ANTERIOR POSTERIOR AXIS; ARTICLE; BLADDER CANCER; BLADDER CAPACITY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; CYSTOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IRRADIATION; MALE; PATIENT SELECTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CONE-BEAM COMPUTED TOMOGRAPHY; CONTRAST MEDIA; CYSTOSCOPY; FEASIBILITY STUDIES; FEMALE; HUMANS; IODIZED OIL; MALE; NETHERLANDS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; UNCERTAINTY; URINARY BLADDER NEOPLASMS;

EID: 77950596029     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.019     Document Type: Article

References (23)

1. Fokdal L., Hoyer M., and von der Maase H. Radical radiotherapy for urinary bladder cancer: Treatment outcomes. Expert Rev Anticancer Ther 6 (2006) 269-279
2. Sengelov L., and von der M.H. Radiotherapy in bladder cancer. Radiother Oncol 52 (1999) 1-14
3. van der Werf-Messing B.H. Cancer of the urinary bladder treated by interstitial radium implant. Int J Radiat Oncol Biol Phys 4 (1978) 373-378
4. Duncan W., and Quilty P.M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7 (1986) 299-310
5. Cowan R.A., McBain C.A., Ryder W.D., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 197-207
6. Mangar S.A., Foo K., Norman A., et al. Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer. Clin Oncol (R Coll Radiol) 18 (2006) 466-473
7. Pos F.J., van Tienhoven G., Hulshof M.C., et al. Concomitant boost radiotherapy for muscle invasive bladder cancer. Radiother Oncol 68 (2003) 75-80
8. Pos F.J., Hulshof M., Lebesque J., et al. Adaptive radiotherapy for invasive bladder cancer: A feasibility study. Int J Radiat Oncol Biol Phys 64 (2006) 862-868
9. Yavuz A.A., Yavuz M.N., Ozgur G.K., et al. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer. Int J Radiat Oncol Biol Phys 56 (2003) 734-745
10. Piet A.H., Hulshof M.C., Pieters B.R., et al. Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Strahlenther Onkol 184 (2008) 313-318
11. Muren L.P., Smaaland R., and Dahl O. Conformal radiotherapy of urinary bladder cancer. Radiother Oncol 73 (2004) 387-398
12. Pos F.J., Koedooder K., Hulshof M.C., van T.G., and Gonzalez G.D. Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 835-841
13. Lotz H.T., Pos F.J., Hulshof M.C., et al. Tumor motion and deformation during external radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1551-1558
14. Hulshof M.C., van Andel G., Bel A., et al. Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas. Radiother Oncol 84 (2007) 49-51
15. Mangar S., Thompson A., Miles E., et al. A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotherapy. Br J Radiol 80 (2007) 279-283
16. Sheehan R, Hreshchyshyn M, Lin RK, LF. The use of lymphography as a diagnostic method. Radiology 1961;72:47-53
17. Dudouet P., Portalez D., Lhez J.M., et al. Trans-rectal ultrasonography (TRUS) with lipiodol injection for localization of the prostatic apex before radiotherapy planning. Radiother Oncol 61 (2001) 135-141
18. Nomori H., Horio H., Naruke T., and Suemasu K. Fluoroscopy-assisted thoracoscopic resection of lung nodules marked with lipiodol. Ann Thorac Surg 74 (2002) 170-173
19. Remeijer P., Nijkamp J., Nijkamp J., et al. Image guidance for bladder cancer based on lipiodol fiducials. [abstract]. J Eur Soc Ther Radiol Oncol 84 (2007) 380
20. van Herk M., Remeijer P., and Lebesque J.V. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 52 (2002) 1407-1422
21. Borgefors G. Hierarchical Chamfer Matching-a parametric edge matching algorithm. IEEE Trans Pattern Analysis Machine Intelligence 10 (1988) 849-865
22. O'Doherty U.M., McNair H.A., Norman A.R., et al. Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol 79 (2006) 335-340
23. Meijer G.J., Rasch C., Remeijer P., and Lebesque J.V. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 55 (2003) 1277-1287